---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-059485"
form_type: "8-K"
ticker: "PEPG"
cik: "0001835597"
company_name: "PepGen Inc."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T01:11:33.565471+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PepGen Q1 net loss $18.0M, cash $175.2M; key clinical data expected mid-2024

## Summary
- Cash and marketable securities $175.2M as of March 31, 2024, funding operations into 2026.
- Net loss widened to $18.0M from $16.3M YoY; R&D expense $14.7M, G&A $5.1M.
- Preliminary CONNECT1-EDO51 data (5 mg/kg dose) expected mid-2024; FDA orphan/rare pediatric designations granted.
- FREEDOM1-DM1 preliminary data from at least 5 mg/kg cohort expected second half 2024.
- Raised $86.3M net from February common stock offerings (ATM + underwritten).

## SEC filing metadata
- accession: 0000950170-24-059485
- form_type: 8-K
- ticker: PEPG
- cik: 0001835597
- company_name: PepGen Inc.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835597/000095017024059485/0000950170-24-059485-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835597/000095017024059485/pepg-20240514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-059485
- JSON: https://secwatch.observer/filing/0000950170-24-059485.json
- Plain text: https://secwatch.observer/filing/0000950170-24-059485.txt

## Key facts
- Earnings Releases
  PepGen Inc. reported financial results for the quarter ended March 31, 2024.
  - Period: the quarter ended March 31, 2024
  - Result: reported results
  source text: On May 14, 2024, PepGen Inc. announced its financial results for the quarter ended March 31, 2024 and other business updates.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835597/000095017024059485/0000950170-24-059485-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.